MiNK Therapeutics, Inc. (INKT)

MiNK Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	13.36	4.58	3.37	19.64	38.89
Cash & Short-Term Investments	13.36	4.58	3.37	19.64	38.89
Cash Growth	191.90%	35.93%	-82.85%	-49.51%	1345.06%
Other Current Assets	0.49	0.41	0.23	0.77	0.75
Total Current Assets	13.85	4.99	3.6	20.4	39.63
Net Property, Plant & Equipment	-	-	0.95	1.07	0.61
Total Assets	14.24	5.72	4.55	21.47	40.24
Accounts Payable	3.43	2.73	3.91	5.82	3
Accrued Expenses	1.58	1.87	5.04	4.24	1.76
Other Current Liabilities	18.28	15.78	13.61	11.7	11.71
Total Current Liabilities	13.03	6.96	11.4	12.68	16.47
Long-Term Debt	5.18	4.92	-	-	-
Other Long-Term Liabilities	-	-	0.05	0.11	-
Total Long-Term Liabilities	5.18	4.92	0.05	0.11	-
Total Liabilities	18.21	11.88	11.45	12.79	16.47
Common Stock	0	0	0	0	0
Additional Paid-in Capital	143.17	125.23	115.77	110.83	107.35
Accumulated Other Comprehensive Income	-0.72	-0.63	-0.43	-0.29	-0.63
Retained Earnings	-156.68	-144.18	-133.4	-110.94	-82.95
Shareholders' Equity	-14.23	-19.59	-18.06	-0.4	23.78
Total Liabilities & Equity	14.24	5.72	4.55	21.47	40.24
Total Debt	5.18	4.92	0	0	0
Net Cash (Debt)	8.18	-0.35	3.37	19.64	38.89
Net Cash Growth	-	-	-82.85%	-49.51%	-
Net Cash Per Share	1.92	-0.09	0.98	5.83	14.94
Book Value	-14.23	-19.59	-18.06	-0.4	23.78
Book Value Per Share	-3.33	-5.19	-5.25	-0.12	9.14
Tangible Book Value	-14.23	-19.59	-18.06	-0.4	23.78
Tangible Book Value Per Share	-3.33	-5.19	-5.25	-0.12	9.14

Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q